R

ise and shine, everyone. The middle of the week is here. Keep a stiff upper lip, though. You made it this far, so why not hang on for another couple of days, yes? And what better way to make the time fly than to keep busy. So grab that cup of stimulation — our flavor today is apple cider donut, a seasonal favorite — and get started. Meanwhile, do keep us in mind if you hear anything interesting. Have a smashing day..

Novo Nordisk (NVO) warned that draft legislation in some U.S. states to make pricing more transparent could impact business in its largest market, Reuters reports. “If the transparency bills lead to a disclosure level that is too excessive, it becomes difficult to do business, for instance, if we have to publicly share what is in our contracts,” Novo chief executive Lars Jorgensen complains.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.